Rising KashmirRising KashmirRising Kashmir
  • Home
  • Top Stories
  • News
    • Kashmir
    • City
    • Jammu
    • Politics
  • Health
  • Anchor
  • Features
  • Interview
  • Video
Search

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022

Categories

  • Anchor
  • Breaking
  • Business
  • City
  • Developing Story
  • Editorial
  • Education
  • Features
  • Health
  • Interview
  • Jammu
  • Jammu and Kashmir News
  • Kashmir
  • Kashmir Tourism
  • Kath Bath
  • National
  • Opinion
  • Politics
  • Sports
  • Technology
  • Top Stories
  • Trending
  • Uncategorized
  • Video
  • Viewpoint
  • World
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: Indian generic drug Paxlovid in high demand in China amid Covid surge
Share
Notification Show More
Font ResizerAa
Rising KashmirRising Kashmir
Font ResizerAa
  • Home
  • Top Stories
  • News
  • Health
  • Anchor
  • Features
  • Interview
  • Video
Search
  • Home
  • Top Stories
  • News
    • Kashmir
    • City
    • Jammu
    • Politics
  • Health
  • Anchor
  • Features
  • Interview
  • Video
Follow US
© 2024. All Rights Reserved.
Rising Kashmir > Blog > Breaking > Indian generic drug Paxlovid in high demand in China amid Covid surge
Breaking

Indian generic drug Paxlovid in high demand in China amid Covid surge

ANI
Last updated: January 9, 2023 11:43 am
ANI
Published: January 9, 2023
Share
4 Min Read
SHARE

As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer’s Covid-19 drug Paxlovid to the community health centres in the coming days, the CNN reported citing state media.

According to the state-run China News Service, after getting trained, community doctors would dispense the medicine to Covid-19 patients and also disseminate information on how to use it. “We have received a notice from officials but it is not clear when the drug will arrive,” CNN cited a worker at a local community health centre in Beijing’s Xicheng district as saying.

Paxlovid remains the only foreign Covid drug that has been approved by China’s regulator for nationwide use, but access to the medicine is a challenging process.

China’s National Health Security Administration informed on Sunday that Pfizer’s Paxlovid oral medicine, which is used to deal with Covid-19, couldn’t be included in the “register of drugs in the basic medical insurance”, as the corporate’s citation was too excessive, media reports said.

Meanwhile, the demand for Indian generic drugs has shot up in China amid the ongoing Covid surge in the country, with specialists cautioning that dubious variations of those drugs were flooding the market.

Due to the large and quick supply of Paxlovid, demand for Indian generic variations via Chinese e-commerce platforms has gone up.

“On the Chinese e-commerce platforms… At least four generic Covid drugs produced in India — Primovir, Paxista, Molnunat, and Molnatris — have been listed for sale in recent weeks. Primovir and Paxista are both generic versions of Paxlovid, while the other two are generic versions of Molnipiravir,” Chinese media outlet Sixth Tone reported.

Following countrywide demonstrations over its ‘Zero Covid’ policy, China abruptly abandoned it last month after nearly three years of lockdowns, quarantines, and mass testing.

The rapid policy change has triggered panic buying of fever and cold medications, resulting in significant shortages at pharmacies and online shopping platforms. Long lineups have become the norm outside fever clinics and hospital wards in the country’s capital, Beijing, and elsewhere, according to CNN.

After China abandoned its ‘Zero Covid’ policy about two weeks ago, regional numbers of infected persons with coronavirus point to explosive outbreaks and overstretched healthcare systems, wrote Chang Che, Asia technology correspondent for The New York Times (NYT).

However, the intensity and magnitude of the country’s first nationwide outbreak have remained a mystery as official figures from the central government remain low.

China’s healthcare system, catering to 1.4 billion people, is reportedly under tremendous strain because of the steep prices of drugs manufactured by multinational pharmaceutical giants.

As things stand, the hospitals are all full, whether government or private, a report said, adding that there is no place for more patients to get admission.

Getting a bed is out of the question, while walkways and aisles are full of patients lying on damp floors, the report said.

The majority of the patients are left to their fates outside of the government health apparatus, the report said, adding that millions do not have access to medicine, oxygen, respiratory machines or other medical equipment.

The only thing they access is a medical drip, it said.

Fears of the elderly losing their lives either to the infection or their comorbidities are growing because of these inadequacies, reported The HK Post, adding that most of the elderly patients are developing other health complications, especially lung infections. (ANI)

Security forces detects Suspicious object on  Handwara-Baramulla road, traffic halted
“Path of resistance will be stronger” says Iran’s President on the killing of Hamas Chief Ismail Haniyeh in Tehran
AAI gets nod to install full-body scanners at 4 airports
PM Modi to launch PM PVTG Development Mission on November 15
Nischal shoots silver in Rio World Cup, breaks national record

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Whatsapp Whatsapp Copy Link Print
Previous Article DAP chief grieved over demise of Great poet Rehman Rahi
Next Article Indian stocks start fresh week in green; Sensex, Nifty up over 1% each
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

1MFollowersLike
262kFollowersFollow
InstagramFollow
234kSubscribersSubscribe
Google NewsFollow

Latest News

Hyderpora underpass turns into cab stand, sparks safety concerns
City
May 26, 2025
Bear-Proof Corral unveiled to tackle human-wildlife conflict in Drass
Kashmir
May 26, 2025
SACPPE holds session to safeguard children from unexploded shells in Uri
Kashmir
May 26, 2025
‘Prem Visheshagya’ brings laughter to Natrangs’ Sunday theatre
Jammu
May 26, 2025

Recent Posts

  • Hyderpora underpass turns into cab stand, sparks safety concerns
  • Bear-Proof Corral unveiled to tackle human-wildlife conflict in Drass
  • SACPPE holds session to safeguard children from unexploded shells in Uri
  • ‘Prem Visheshagya’ brings laughter to Natrangs’ Sunday theatre
  • Admin spreads awareness on drug abuse in Sgr

Recent Comments

  1. SavePlus on AI and Behavioural Analytics in Gaming: Making the World of Gaming Better
  2. Parul on Govt acknowledges faulty streetlights on Narbal-Tangmarg road
  3. dr gora on Women Veterinarians and the Goal of Viksit Bharat
  4. jalwa game login on National Education Policy 2020: Transforming India’s Educational System
  5. Virender Bhat on Pahalgam Attack: A War on Humanity, Peace, and Kashmiriyat

Contact Us

Flat No 7,Press Enclave, Srinagar, 190001
0194 2477887
9971795706
[email protected]
[email protected]

Quick Link

  • E-Paper
  • About Us
  • Contact Us

Top Categories

Stay Connected

1.06MLike
262.5kFollow
InstagramFollow
234.3kSubscribe
WhatsAppFollow
Rising KashmirRising Kashmir
Follow US
© 2025. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?